Inhibition of Hepatitis Delta Virus Genomic Ribozyme Self-Cleavage by Aminoglycosides.

Subgenomic regions of hepatitis delta virus (HDV) RNA contains ribozyme whose activities are important to viral life cycles and depend on a unique pseudoknot structure. To explore the characters of HDV ribozyme, antibiotics of the aminoglycoside, which has been shown inhibiting self-splicing of group I intron and useful in elucidating its structure, were tested for their effect on HDV genomic ribozyme. Aminoglycosides, including tobramycin, netromycin, neomycin and gentamicin effectively inhibited HDV genomic ribozyme self-cleavage in vitro at a concentration comparable to that inhibiting group I intron self-splicing. The extent of inhibition depended upon the concentration of magnesium ion. Chemical modification mapping of HDV ribozyme RNA indicated that the susceptibility of nucleotide 703 to the modifying agent was enhanced in the presence of tobramycin, suggesting a conformational shift of HDV ribozyme, probably due to an interaction with the aminoglycoside. Finally, we examined the effect of aminoglycoside on HDV cleavage and replication in cell lines, however, none of the aminoglycoside effective in vitro exerted suppressive effects in vivo. Our results represented as an initial effort in utilizing aminoglycoside to probe the structure of HDV ribozyme and to compare its reaction mechanism with those of other related ribozymes.

[1]  H. Noller,et al.  Footprinting the sites of interaction of antibiotics with catalytic group I intron RNA. , 1993, Science.

[2]  Shinji Makino,et al.  Molecular cloning and sequencing of a human hepatitis delta (δ) virus RNA , 1987, Nature.

[3]  J. Taylor,et al.  Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus , 1988, Journal of virology.

[4]  J. Taylor,et al.  Ribonucleoprotein complexes of hepatitis delta virus , 1993, Journal of virology.

[5]  H. Schellekens,et al.  The hepatitis delta (δ) virus possesses a circular RNA , 1986, Nature.

[6]  H. Robertson,et al.  Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. T. Perrotta,et al.  Cleavage of oligoribonucleotides by a ribozyme derived from the hepatitis delta virus RNA sequence. , 1992, Biochemistry.

[8]  M. Lai,et al.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Schroeder,et al.  8 Antibiotics and the RNA World: A Role for Low-molecular-weight Effectors in Biochemical Evolution? , 1993 .

[10]  M. Lai,et al.  Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites , 1993, Journal of virology.

[11]  J. Gerin,et al.  Antigens of hepatitis delta virus in the liver and serum of humans and animals. , 1986, The Journal of infectious diseases.

[12]  H. Noller.  Ribosomal RNA and translation. , 1991, Annual review of biochemistry.

[13]  S. Rosenstein,et al.  Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions. , 1990, Biochemistry.

[14]  R. Symons,et al.  Small catalytic RNAs. , 1992, Annual review of biochemistry.

[15]  Harry F. Noller,et al.  Interaction of antibiotics with functional sites in 16S ribosomal RNA , 1987, Nature.

[16]  H. Wu,et al.  Continuous expression and replication of the hepatitis delta virus genome in Hep G2 hepatoblastoma cells transfected with cloned viral DNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Taira,et al.  Self-cleavage activity of the genomic HDV ribozyme in the presence of various divalent metal ions. , 1993, Nucleic acids research.

[18]  J. Taylor,et al.  The structure and replication of hepatitis delta virus. , 1992, Annual review of microbiology.

[19]  K. Taira,et al.  Chemical probing studies of variants of the genomic hepatitis delta virus ribozyme by primer extension analysis. , 1994, Biochemistry.

[20]  H. Noller,et al.  Rapid chemical probing of conformation in 16 S ribosomal RNA and 30 S ribosomal subunits using primer extension. , 1986, Journal of molecular biology.

[21]  R. Schroeder,et al.  Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. , 1996, Journal of molecular biology.

[22]  J. Davies,et al.  Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics. , 1992, Journal of molecular biology.

[23]  T. O. Diener.  Circular RNAs: relics of precellular evolution? , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Michael Houghton,et al.  Structure, sequence and expression of the hepatitis delta (δ) viral genome , 1986, Nature.

[25]  J. Taylor,et al.  Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage , 1988, Journal of virology.

[26]  M. Lai,et al.  Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo , 1996, Journal of virology.

[27]  J. Davies,et al.  Antibiotic inhibition of group I ribozyme function , 1991, Nature.

[28]  M. Lai.  The molecular biology of hepatitis delta virus. , 1990, Annual review of biochemistry.

[29]  Harry F. Noller,et al.  Transfer RNA shields specific nucleotides in 16S ribosomal RNA from attack by chemical probes , 1986, Cell.

[30]  R. Purcell,et al.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Robertson,et al.  A replication cycle for viroids and other small infectious RNA's. , 1984, Science.

[32]  P. Carbon,et al.  A guide for probing native small nuclear RNA and ribonucleoprotein structures. , 1989, Methods in enzymology.

[33]  J. Taylor,et al.  Structure and replication of the genome of hepatitis delta virus. , 1986, Progress in clinical and biological research.

[34]  A. T. Perrotta,et al.  A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA , 1991, Nature.

[35]  M. Lai,et al.  Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. , 1992, Journal of molecular biology.

[36]  A. T. Perrotta,et al.  The self-cleaving domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant. , 1990, Nucleic acids research.

[37]  O. Uhlenbeck,et al.  Neomycin inhibition of the hammerhead ribozyme involves ionic interactions. , 1995, Biochemistry.

[38]  H. Wu,et al.  Mutagenesis analysis of a hepatitis delta virus genomic ribozyme. , 1993, Nucleic acids research.

[39]  T. Cech,et al.  Secondary structure of the circular form of the Tetrahymena rRNA intervening sequence: a technique for RNA structure analysis using chemical probes and reverse transcriptase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Westhof,et al.  A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses , 1994, Current Biology.

[41]  G. Dinter-Gottlieb,et al.  Non-ribozyme sequences enhance self-cleavage of ribozymes derived from Hepatitis delta virus. , 1991, Nucleic acids research.

[42]  R. Schroeder,et al.  Splice-site selection and decoding: are they related? , 1993, Science.

[43]  Point and compensation mutations to evaluate essential stem structures of genomic HDV ribozyme , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  W. Gilbert,et al.  Chemical probes for higher-order structure in RNA. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Taylor,et al.  Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications , 1988, Journal of virology.